These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16269936)

  • 1. Cleavage of von Willebrand factor by ADAMTS-13 in vitro: effect of temperature and barium ions on the proteolysis kinetics.
    Perutelli P; Amato S; Molinari AC
    Blood Coagul Fibrinolysis; 2005 Nov; 16(8):607-11. PubMed ID: 16269936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The O-linked glycans of human von Willebrand factor modulate its interaction with ADAMTS-13.
    Nowak AA; McKinnon TA; Hughes JM; Chion AC; Laffan MA
    J Thromb Haemost; 2014 Jan; 12(1):54-61. PubMed ID: 24406064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mapping of the chloride-binding site in von Willebrand factor (VWF): energetics and conformational effects on the VWF/ADAMTS-13 interaction.
    De Cristofaro R; Peyvandi F; Baronciani L; Palla R; Lavoretano S; Lombardi R; Di Stasio E; Federici AB; Mannucci PM
    J Biol Chem; 2006 Oct; 281(41):30400-11. PubMed ID: 16899464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of chloride ions in modulation of the interaction between von Willebrand factor and ADAMTS-13.
    De Cristofaro R; Peyvandi F; Palla R; Lavoretano S; Lombardi R; Merati G; Romitelli F; Di Stasio E; Mannucci PM
    J Biol Chem; 2005 Jun; 280(24):23295-302. PubMed ID: 15809291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-step binding of ADAMTS-13 to von Willebrand factor.
    Feys HB; Anderson PJ; Vanhoorelbeke K; Majerus EM; Sadler JE
    J Thromb Haemost; 2009 Dec; 7(12):2088-95. PubMed ID: 19765212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc and calcium ions cooperatively modulate ADAMTS13 activity.
    Anderson PJ; Kokame K; Sadler JE
    J Biol Chem; 2006 Jan; 281(2):850-7. PubMed ID: 16286459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemoglobin blocks von Willebrand factor proteolysis by ADAMTS-13: a mechanism associated with sickle cell disease.
    Zhou Z; Han H; Cruz MA; López JA; Dong JF; Guchhait P
    Thromb Haemost; 2009 Jun; 101(6):1070-7. PubMed ID: 19492149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel, semi-automated, 60-min-assay to determine von Willebrand factor cleaving activity of ADAMTS-13.
    Kostousov V; Fehr J; Bombeli T
    Thromb Res; 2006; 118(6):723-31. PubMed ID: 16430944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a core binding site for ADAMTS-13 in the A2 domain of von Willebrand factor.
    Wu JJ; Fujikawa K; McMullen BA; Chung DW
    Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18470-4. PubMed ID: 17121983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet von Willebrand factor: sweet resistance.
    Lenting PJ; Denis CV
    Blood; 2013 Dec; 122(25):4006-7. PubMed ID: 24335029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidized von Willebrand factor is efficiently cleaved by serine proteases from primary granules of leukocytes: divergence from ADAMTS-13.
    Lancellotti S; De Filippis V; Pozzi N; Oggianu L; Rutella S; Scaglione GL; Maset F; Peyvandi F; Mannucci PM; De Cristofaro R
    J Thromb Haemost; 2011 Aug; 9(8):1620-7. PubMed ID: 21605335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assays of ADAMTS-13 activity.
    Veyradier A; Girma JP
    Semin Hematol; 2004 Jan; 41(1):41-7. PubMed ID: 14727258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-function and regulation of ADAMTS-13 protease.
    Zheng XL
    J Thromb Haemost; 2013 Jun; 11 Suppl 1(0 1):11-23. PubMed ID: 23809107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium stabilizes the von Willebrand factor A2 domain by promoting refolding.
    Xu AJ; Springer TA
    Proc Natl Acad Sci U S A; 2012 Mar; 109(10):3742-7. PubMed ID: 22357761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmatic ADAMTS-13 metalloprotease and von Willebrand factor in children with cyanotic congenital heart disease.
    Soares RP; Bydlowski SP; Nascimento NM; Thomaz AM; Bastos EN; Lopes AA
    Braz J Med Biol Res; 2013 Apr; 46(4):375-81. PubMed ID: 23558858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura.
    Zhou Z; Nguyen TC; Guchhait P; Dong JF
    Semin Thromb Hemost; 2010 Feb; 36(1):71-81. PubMed ID: 20391298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling ADAMTS13-von Willebrand factor interaction: Implications for oxidative stress-related cardiovascular diseases and type 2A von Willebrand disease.
    Pozzi N; Lancellotti S; De Cristofaro R; De Filippis V
    Biophys Chem; 2012 Jan; 160(1):1-11. PubMed ID: 21937160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of ADAMTS-13 activity in plasma using recombinant von Willebrand Factor A2 domain polypeptide as substrate.
    Cruz MA; Whitelock J; Dong JF
    Thromb Haemost; 2003 Dec; 90(6):1204-9. PubMed ID: 14652658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of von Willebrand factor regulate ADAMTS-13, its major cleaving protease.
    Mannucci PM; Capoferri C; Canciani MT
    Br J Haematol; 2004 Jul; 126(2):213-8. PubMed ID: 15238142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of naturally occurring mutations in CUB-1 domain on synthesis, stability, and activity of ADAMTS-13.
    Zhou Z; Jing H; Tao Z; Choi H; Aboulfatova K; Moake J; Li R; Dong JF
    Thromb Res; 2009 Jul; 124(3):323-7. PubMed ID: 19027144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.